3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
9
Phase 1
2
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
6
Lymphoid
6
Thoracic
4
Gastrointestinal
4
Plasma cell
2
Dermatologic
2
CNS
2
Breast
2
Sarcoma
1
Gynecologic
1
Genitourinary
1
Conditions
Ovarian Neoplasms
325
Uterine Cervical Neoplasms
131
Endometrial Neoplasms
109
Breast Neoplasms
99
Carcinoma, Non-Small-Cell Lung
85
Fallopian Tube Neoplasms
77
Colorectal Neoplasms
74
Carcinoma, Ovarian Epithelial
71
Neoplasms
63
Pancreatic Neoplasms
62
Stomach Neoplasms
59
Melanoma
57
Neoplasm Metastasis
51
Triple Negative Breast Neoplasms
49
Squamous Cell Carcinoma of Head and Neck
43
Prostatic Neoplasms
42
Lung Neoplasms
41
Esophageal Neoplasms
40
Head and Neck Neoplasms
39
Urinary Bladder Neoplasms
32
Carcinoma, Renal Cell
31
Sarcoma
29
Recurrence
28
Small Cell Lung Carcinoma
26
Colonic Neoplasms
25
Carcinoma, Hepatocellular
24
Carcinoma, Transitional Cell
20
Uterine Neoplasms
16
Peritoneal Neoplasms
15
Mesothelioma
15
Interventions
pembrolizumab
1
Interleukin-15
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Disease
×
Gynecologic
×
Clear all
NCT07410676
2026-02-18
EBNK-ST-001
Essen Biotech
Phase 1/2
Recruiting
83 enrolled